31 related articles for article (PubMed ID: 6829982)
1. Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.
Jullien V; Hubert D; Launay O; Babany G; Lortholary O; Sermet I
Antimicrob Agents Chemother; 2011 Sep; 55(9):4183-7. PubMed ID: 21670188
[TBL] [Abstract][Full Text] [Related]
2. Theophylline poisoning. Pharmacological considerations and clinical management.
Gaudreault P; Guay J
Med Toxicol; 1986; 1(3):169-91. PubMed ID: 3537617
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics in infants and children. A reappraisal.
Kearns GL; Reed MD
Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
[TBL] [Abstract][Full Text] [Related]
4. Absorption of sustained-release theophylline tablets.
Fagerström PO; Heintz L
Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
[TBL] [Abstract][Full Text] [Related]
5. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
[TBL] [Abstract][Full Text] [Related]
6. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
7. The influence of enteral feedings on sustained-release theophylline absorption.
Plezia PM; Thornley SM; Kramer TH; Armstrong EP
Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
[TBL] [Abstract][Full Text] [Related]
8. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
10. Slow-release theophylline for the management of chronic asthma.
Hendeles L; Weinberger M
Singapore Med J; 1985 Feb; 26(1):83-90. PubMed ID: 3895446
[No Abstract] [Full Text] [Related]
11. Clinical pharmacology. Series on pharmacology in practice. 4. Theophylline. Practical application of new knowledge.
Van Dellen RG
Mayo Clin Proc; 1979 Nov; 54(11):733-45. PubMed ID: 386000
[No Abstract] [Full Text] [Related]
12. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
Wagner JG
Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
